क्लिनिकल माइक्रोबायोलॉजी के अभिलेखागार

  • आईएसएसएन: 1989-8436
  • जर्नल एच-इंडेक्स: 22
  • जर्नल उद्धरण स्कोर: 7.55
  • जर्नल प्रभाव कारक: 6.38
में अनुक्रमित
  • जे गेट खोलो
  • जेनेमिक्स जर्नलसीक
  • वैश्विक प्रभाव कारक (जीआईएफ)
  • पुरालेख पहल खोलें
  • चीन राष्ट्रीय ज्ञान अवसंरचना (सीएनकेआई)
  • रिसर्च जर्नल इंडेक्सिंग की निर्देशिका (डीआरजेआई)
  • ओसीएलसी- वर्ल्डकैट
  • प्रोक्वेस्ट सम्मन
  • पबलोन्स
  • मियार
  • विश्वविद्यालय अनुदान आयोग
  • चिकित्सा शिक्षा और अनुसंधान के लिए जिनेवा फाउंडेशन
  • गूगल ज्ञानी
  • स्किमागो जर्नल रैंकिंग
  • गुप्त खोज इंजन लैब्स
  • अनुसंधान गेट
इस पृष्ठ को साझा करें

अमूर्त

Microbial Profile of Burn Wound Infections in Burn Patients, Taif, Saudi Arabia

Khadijah Yousef AL-Aali

The major challenge for a burn team is nosocomial infection in burn patients, which is known to cause over 50% of burn deaths, and represents a serious health problem in burn wound patients,Taif, Sudia Arabia.
Aim: To determine Microbial Profile of Burn Wound Infections in Burn Patients,Taif, Saudi Arabia.
Method: 220 patients were included in the study. Woundswab cultures were assessed at day 4. Two hundred and twenty sampling procedures (surface swabs) were performed from the burn wounds.
Result: The study revealed that bacterial infection at least once reached 100% by the end of the 4th week of admission. Staphylococcus aureus, Klebsiella pneumoniae and coagulase negative Staphylococci were the most frequently isolated organisms, each representing 20.2%, followed by Pseudomonas aeruginosa 14.6% and E. coli 10.1%. Fungi were found to cause burn wound invasion late during the second week post burn, with the highest incidence during the fourth week, reaching 36% by the end of the 4th week of admission. Candida spp. (66.7%). The susceptibility pattern of 745 bacteria isolated against 20 antimicrobial agents. All strains were susceptible to all antibiotic; resistance was observed in some strains.
Conclusion: This would enable early treatment of imminent septic episodes with proper empirical systemic antibiotics, without waiting for culture results, thus improving the overall infection related morbidity and mortality.